H-1B sponsorship profile: Albert B Sabin Vaccine Institute, Inc. Across U.S. Department of Labor LCA disclosures, Albert B Sabin Vaccine Institute, Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Albert B Sabin Vaccine Institute, Inc’s H-1B petitions range from $92,400 at the low end to $115,669 at the high end, with a petition-weighted average of $100,156. That range reflects the mix of occupations the company sponsors, led by Manager, Program Strategy (Global Immunization) (2 petitions at $92,400 avg), followed by Senior Project Manager, Research & Development. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Albert B Sabin Vaccine Institute, Inc is headquartered in Washington, DC under NAICS code 325414, and places H-1B workers across 3 states, most heavily in MD, NY, NC. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Albert B Sabin Vaccine Institute, Inc ranks. By H-1B petition volume, Albert B Sabin Vaccine Institute, Inc is #37,433 of 119,880 employers nationally and #274 of 1,005 employers headquartered in DC. Both ranks are computed live from the same underlying petition counts, not a separate estimate.